PRO2 BASED REMOTE MONITORING IN ULCERATIVE COLITIS: A PROSPECTIVE REAL WORLD STUDY

被引：1
|
作者：
Sebastian, S. [1 ]
Roberts, J. [2 ]
Waller, J. [2 ]
Judge, D. [3 ]
Brown, C. [4 ]
Davies, R. [4 ]
Kachroo, S. [5 ]
机构：
[1] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[2] Adelphi Real World, Bollington, England
[3] Adelphi Real World, Manchester, Lancs, England
[4] Merck Sharp & Dohme Ltd, Hoddesdon, Herts, England
[5] Merck & Co Inc, Kenilworth, NJ USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1791
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY77
引用
下载
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [21] Ulcerative colitis: Tofacitinib under real-world conditions
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (12): : 1565 - +
  • [22] Real-world effectiveness of adalimumab in patients with ulcerative colitis
    Armuzzi, A.
    Taxonera, C.
    Panes, J.
    Lakatos, P.
    Fisseha, N.
    Pappalardo, B.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S280 - S282
  • [23] Editorial: real-world safety of tofacitinib in ulcerative colitis
    Taxonera, Carlos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (03) : 368 - 369
  • [24] Real World Use and Effectiveness of Golimumab for Ulcerative Colitis in Canada
    Bressler, Brian
    Williamson, Martin A.
    Camacho, Fernando
    Sattin, Bernie D.
    Steinhart, A. Hillary
    GASTROENTEROLOGY, 2016, 150 (04) : S811 - S811
  • [25] Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence
    Olivera, Pablo
    Danese, Silvio
    Pouillon, Lieven
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (03) : 327 - 334
  • [26] VEDOLIZUMAB(VDZ) REAL WORLD OUTCOMES IN ULCERATIVE COLITIS (UC)
    Pulusu, Samba Siva Reddy
    Srinivasan, Ashish
    Krishnaprasad, Krupa
    Cheng, Daniel
    Mogilevski, Tamara
    Flanagan, Emma
    Keung, Charlotte
    Wu, Yang
    Prosser, Ruth
    Sawyer, Elise A.
    Rizvi, Quart-Ul-Ain
    Su, Heidi Y.
    Leung, Wai K.
    Edmundson, Aleksandra
    Cooke, Sharon
    Mahy, Gillian
    Thin, Lena
    Radford-Smith, Graham L.
    Sparrow, Miles
    Andrews, Jane M.
    Connor, Susan J.
    Bampton, Peter A.
    Simon, Ghaly
    van Langenberg, Daniel R.
    Bell, Sally
    De Cruz, Peter
    Begun, Jakob
    Ng, Siew C.
    Travis, Simon P.
    Lawrance, Ian
    GASTROENTEROLOGY, 2018, 154 (06) : S836 - S836
  • [27] Initial 8-week Therapy with Tofacitinib in Moderate-to-Severe Ulcerative Colitis in a Real World Prospective Multicenter Study (TOUR)
    Long, Millie D.
    Afzali, Anita
    Fisher, Monika
    English, Emily
    Zhang, Xian
    Hudesman, David
    Abdalla, Maisa
    McCabe, Robert P.
    Cohen, Benjamin
    Harlan, William
    Hanson, John
    Konijeti, Gauree G.
    Polyak, Steven
    Ritter, Timothy E.
    Salzberg, Bruce
    Herfarth, Hans
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S440 - S441
  • [28] Pseudopotential study of PrO2 and HfO2 in fluorite phase
    Dabrowski, J
    Zavodinsky, V
    Fleszar, A
    MICROELECTRONICS RELIABILITY, 2001, 41 (07) : 1093 - 1096
  • [29] Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience
    Friedberg, Scott
    Choi, David
    Hunold, Thomas
    Choi, Natalie K.
    Garcia, Nicole M.
    Picker, Emma A.
    Cohen, Nathaniel A.
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Sakuraba, Atsushi
    Cleveland, Noa Krugliak
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1913 - +
  • [30] Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea
    Kim, Dae Bum
    Lee, Kang-Moon
    Park, Sang Hyoung
    Kim, You Sun
    Kim, Eun Soo
    Lee, Jun
    Jung, Sung-Ae
    Seo, Geom Seog
    Lee, Ji Min
    INTESTINAL RESEARCH, 2018, 16 (02) : 267 - 272
12345